Histopathology based AI model predicts anti-angiogenic therapy response in renal cancer clinical trial

Abstract Anti-angiogenic (AA) therapy is a cornerstone of metastatic clear cell renal cell carcinoma (ccRCC) treatment, but not everyone responds, and predictive biomarkers are lacking. CD31, a marker of vasculature, is insufficient, and the Angioscore, an RNA-based angiogenesis quantification metho...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jay Jasti, Hua Zhong, Vandana Panwar, Vipul Jarmale, Jeffrey Miyata, Deyssy Carrillo, Alana Christie, Dinesh Rakheja, Zora Modrusan, Edward Ernest Kadel, Niha Beig, Mahrukh Huseni, James Brugarolas, Payal Kapur, Satwik Rajaram
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2025-03-01
Col·lecció:	Nature Communications
Accés en línia:	https://doi.org/10.1038/s41467-025-57717-6
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!